FATE THERAPEUTICS INC (FATE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FATE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FATE | Director | 70 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VCYT | «Board of Directors member, Fate Therapeutics, Inc. and Illumina, Inc.; Chair of the Board of Directors | 70 | ["Strategic consultant to life sciences companies since 2013","Former President of the Medco-UBC Division","Chief Research and Development Officer of Medco Health Solutions, Inc.","Chief Medical Officer of Medco from 1997 to 2010","Board member of Fate Therapeutics, Inc. since March 2014","Board member of Illumina, Inc. since November 2012","Former board member of Aveo Pharmaceuticals, Inc. from 2012 to 2014","Former Chairman of the Board of Decipher Biosciences, Inc. from 2019 to 2021","Former president of the International Society of Pharmacoeconomics and Outcomes Research","Served on the board of directors of the Drug Information Association","Served on the board of the International Society of Quality of Life","Experience with Centers for Disease Control and Prevention Committee","Experience with Agency for Healthcare Research and Quality Committee","Holds a B.S. in Biomedical Science","Holds an M.D. from the University of Michigan","Holds an M.S. in Preventive Medicine from the University of Maryland"] | ["Compensation","Nominating and Corporate Governance"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Epstein holds a B.S. and an M.D. from the University of Michigan and an M.S. from the University of Maryland. The Board of Directors has determined that Dr. Epstein s extensive operating, commercial, and senior management experience in the biotechnology industry, as well as his expertise in health economics, qualifies him to serve as a member of our Board of Directors.